Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
48.68 USD | -0.48% | -22.78% | +347.58% |
05-08 | Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating | MT |
05-08 | Janux Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- JANX Stock
- News Janux Therapeutics, Inc.
- MarketScreener Strategies